BRIAN LOS: Open Payments
NPI 1497747588 · TITUSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,896 in 113 payments from 26 companies in 2025. Trend: 2023 $2,630 · 2024 $2,226 · 2025 $1,896
Food & beverage: $1,896
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $216 |
| ABBVIE INC. | 19 | $202 |
| AstraZeneca Pharmaceuticals LP | 9 | $183 |
| Astellas Pharma US Inc | 7 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $159 |
| PFIZER INC. | 11 | $153 |
| Madrigal Pharmaceuticals | 4 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $100 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
Products named: Veozah, CAPLYTA, VRAYLAR, REZDIFFRA, BREZTRI, Ozempic, JARDIANCE, Auvelity.
Industry payments across PA — which companies pay providers there.
